52927-98-7 Usage
Uses
Used in Organic Synthesis:
2-bromo-1-(2-bromoethyl)-4-chlorobenzene is utilized as a building block in organic synthesis for creating new molecules and materials with specific properties and functions. Its reactivity allows for the formation of various chemical bonds, facilitating the development of complex organic compounds.
Used in Pharmaceutical Production:
In the pharmaceutical industry, 2-bromo-1-(2-bromoethyl)-4-chlorobenzene serves as an intermediate in the synthesis of various drugs. Its unique structure contributes to the development of medications with targeted therapeutic effects.
Used in Agrochemical Production:
Similarly, in agrochemical manufacturing, 2-bromo-1-(2-bromoethyl)-4-chlorobenzene is employed as an intermediate. It aids in the production of pesticides, herbicides, and other agricultural chemicals that are designed to improve crop yields and protect plants from pests and diseases.
It is crucial to handle and use 2-bromo-1-(2-bromoethyl)-4-chlorobenzene with care, as it can pose risks to human health and the environment if not properly managed.
Check Digit Verification of cas no
The CAS Registry Mumber 52927-98-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,9,2 and 7 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 52927-98:
(7*5)+(6*2)+(5*9)+(4*2)+(3*7)+(2*9)+(1*8)=147
147 % 10 = 7
So 52927-98-7 is a valid CAS Registry Number.
52927-98-7Relevant academic research and scientific papers
HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME
-
, (2016/01/25)
Disclosed are chemical entities which are compounds of formula (I); or pharmaceutically acceptable salts thereof; wherein Y, Ra, Ra', Rb, Rc, X1, X2, X3, Rd, Z1, and Z2 have the values described herein and stereochemical configurations depicted at asterisked positions indicate absolute stereochemistry. Chemical entities according to the disclosure can be useful as inhibitors of Sumo Activating Enzyme (SAE). Further provided are pharmaceutical compositions comprising a compound of the disclosure and methods of using the compositions in the treatment of proliferative, inflammatory, cardiovascular, and neurodegenerative diseases or disorders.
